**ProAssurance Corporation Reports Fiscal Year 2025 Results**
ProAssurance Corporation (NYSE: PRA) reported net premiums written of $916.9 million for the year ended December 31, 2025, a decrease of $36.8 million compared to $953.7 million in 2024. Net premiums earned also decreased to $934.2 million from $968.3 million in the prior year. The company's total assets stood at $5.4 billion, while shareholders' equity reached $1.3 billion as of December 31, 2025.
The company's net income for 2025 was $50.9 million, or $0.99 per diluted share, compared to $52.7 million, or $1.03 per diluted share, in 2024. The net loss ratio improved to 71.2% from 76.4%, while the underwriting expense ratio increased to 35.4% from 33.0%. The combined ratio, a measure of underwriting profitability, was 106.6% in 2025, compared to 109.4% in 2024. Net investment income increased to $156.5 million from $144.5 million, while the company experienced net investment losses of $5.5 million compared to net investment gains of $1.9 million in the previous year.
Strategic developments during the year included an agreement to be acquired by The Doctors Company, with the merger expected to close by June 30, 2026, pending regulatory approvals. ProAssurance also sold the renewal rights related to its legal professional liability book of business for $1.0 million. The company's employee headcount was 972 as of December 31, 2025, with no employees represented by a labor union.
Looking ahead, ProAssurance anticipates closing the merger transaction with The Doctors Company by June 30, 2026. The company will continue to focus on rate adequacy, disciplined underwriting, and effective claims management to achieve its long-term financial objectives. ProAssurance is also investing in innovation solutions, including artificial intelligence and process automation, to enhance risk selection, decision making, and workflows.
About PROASSURANCE CORP
ProAssurance Corporation is a specialty insurance holding company providing property and casualty coverage, primarily medical professional liability, medical technology liability, and workers' compensation insurance. Serving healthcare providers, medical device companies, and related markets, it emphasizes risk management, claims handling, and innovative solutions. Its business model focuses on profitable underwriting, strong customer relationships, operational excellence, and strategic capital management within the U.S. and international markets.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.